| 000 | 01624 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250514182549.0 | ||
| 264 | 0 | _c20040713 | |
| 008 | 200407s 0 0 eng d | ||
| 022 | _a1462-0324 | ||
| 024 | 7 |
_a10.1093/rheumatology/keh168 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPoór, G | |
| 245 | 0 | 0 |
_aEfficacy and safety of leflunomide 10 mg versus 20 mg once daily in patients with active rheumatoid arthritis: multinational double-blind, randomized trial. _h[electronic resource] |
| 260 |
_bRheumatology (Oxford, England) _cJun 2004 |
||
| 300 |
_a744-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aIsoxazoles _xadministration & dosage |
| 650 | 0 | 4 | _aLeflunomide |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aStrand, V | |
| 773 | 0 |
_tRheumatology (Oxford, England) _gvol. 43 _gno. 6 _gp. 744-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/rheumatology/keh168 _zAvailable from publisher's website |
| 999 |
_c14744758 _d14744758 |
||